The National University Hospital is a tertiary referral hospital in Singapore, located in Kent Ridge.

There are 1,239 beds in National University Hospital.

During the past decade, National University Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National University Hospital" #1 sponsor was "National University Hospital, Singapore" with 2 trials, followed by "Genmab" with 1 trials sponsored, "Menzies School of Health Research" with 1 trials sponsored, "National Healthcare Group, Singapore" with 1 trials sponsored and "National University Health System, Singapore" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National University Hospital" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Australasian Kidney Trials Network" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Changi General Hospital" with 1 trials as a collaborator and "Chinese University of Hong Kong" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "National University Hospital" are "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials), "Colorectal Cancer" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Gastrectomy" (1 trials). Many other conditions were trialed in "National University Hospital" in a lesser frequency.

Most popular intervention types in "National University Hospital" are "Drug" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "12.5mg sunitinib with Cisplatin and Gemcitabine" (1 trials), "2.5mg/kg Bevacizumab alternating with Cisplatin and Gemcitabine" (1 trials), "25mg Sunitinib alternating with Cisplatin and Gemcitabine" (1 trials), "7.5mg/kg Bevacizumab alternating with Cisplatin and Gemcitabine" (1 trials) and "APN-led Telemedicine" (1 trials). Other intervention names were less common.

The vast majority of trials in "National University Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "National University Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in National University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".